Earnings Recap

KRISHANA.NS Earnings: Phoschem Reports $7.55B Revenue on May 4

Key Points

Krishana Phoschem reports $7.55B revenue and $13.44 EPS on May 4.

Stock surges 5.77% to $634.70 with strong trading volume.

Company maintains 40.65% ROE and 7.45% net profit margins.

Meyka AI rates KRISHANA.NS with B+ grade, suggesting neutral positioning.

Be the first to rate this article

Krishana Phoschem Limited, India’s leading fertilizer and chemical manufacturer, delivered strong earnings results on May 4, 2026. The company reported $7.55 billion in revenue and $13.44 earnings per share, demonstrating solid operational performance in the agricultural inputs sector. KRISHANA.NS stock surged 5.77% following the announcement, closing at $634.70 with robust trading volume. The results reflect the company’s continued strength in producing benefited rock phosphate, single super phosphate, and specialty chemicals. Meyka AI rates KRISHANA.NS with a grade of B+, suggesting neutral positioning with strong operational fundamentals.

Earnings Performance and Market Reaction

Krishana Phoschem delivered impressive financial results that resonated positively with investors. The company reported $7.55 billion in total revenue and $13.44 earnings per share, showcasing robust profitability in a competitive market.

Stock Price Surge

Market sentiment turned decisively positive following the earnings release. KRISHANA.NS stock jumped 5.77% to $634.70, with the day’s trading range spanning from $613.05 to $637.00. Trading volume reached 363,870 shares, significantly exceeding the average daily volume of 200,846 shares. This 81% increase in relative volume indicates strong investor interest and confidence in the company’s performance trajectory.

Revenue and Profitability Metrics

The $7.55 billion revenue figure represents substantial scale in India’s agricultural chemicals sector. With 61.83 million shares outstanding, the company maintains a $37.78 billion market capitalization. The earnings per share of $13.44 reflects effective cost management and operational efficiency across the company’s diverse product portfolio including fertilizers, dyes, and specialty chemicals.

Financial Health and Valuation Metrics

Krishana Phoschem demonstrates solid financial positioning with balanced leverage and reasonable valuation multiples. The company’s capital structure and profitability ratios provide insight into operational sustainability.

Valuation and Earnings Multiples

The stock trades at a P/E ratio of 20.96, reflecting moderate valuation relative to earnings power. The price-to-sales ratio of 1.56 suggests reasonable pricing compared to revenue generation. With a price-to-book ratio of 6.74, the stock commands a premium reflecting investor confidence in management execution and growth prospects. The PEG ratio of 0.19 indicates attractive valuation relative to expected earnings growth.

Balance Sheet Strength

Krishana Phoschem maintains a debt-to-equity ratio of 1.31, indicating moderate leverage typical for capital-intensive chemical manufacturers. The current ratio of 1.36 demonstrates adequate short-term liquidity to meet obligations. Interest coverage of 9.31 times shows comfortable debt servicing capacity. The company’s return on equity of 40.65% and return on assets of 10.98% reflect efficient capital deployment and strong profitability generation.

Operational Efficiency and Growth Trajectory

The company demonstrates consistent operational improvements and strategic positioning within India’s agricultural sector. Recent financial growth metrics reveal steady expansion and margin enhancement.

Revenue and Profitability Growth

Krishana Phoschem achieved 1.32% revenue growth in the latest fiscal year, reflecting steady market demand for fertilizers and chemicals. Gross profit expanded 5.25%, outpacing revenue growth and indicating improved product mix and pricing power. Operating income grew 2.74%, while net income increased 1.14%, demonstrating controlled expense management. The net profit margin of 7.45% reflects solid profitability despite competitive pressures in the agricultural inputs industry.

Operational Metrics and Efficiency

The company’s inventory turnover of 5.79 times indicates efficient production and inventory management. Receivables turnover of 3.35 times with 109 days sales outstanding reflects typical credit terms in the agricultural sector. The operating cycle of 172 days is balanced by 45-day payables, resulting in a 126-day cash conversion cycle. These metrics demonstrate effective working capital management supporting operational cash flow generation.

Market Position and Forward Outlook

Krishana Phoschem operates in India’s dynamic agricultural chemicals sector with strong competitive positioning. The company’s diversified product portfolio and operational scale support continued market relevance.

Sector and Industry Standing

The company operates in the Basic Materials sector within the Agricultural Inputs industry, serving India’s critical fertilizer and specialty chemical needs. With 2,850 full-time employees and facilities in Bhilwara, Rajasthan, Krishana Phoschem maintains significant production capacity. The company manufactures benefited rock phosphate, single super phosphate, H-acid, intermediate dyes, sulphuric acid, and specialty products under the Annadata brand, serving diverse agricultural and industrial customers.

Price Forecasts and Technical Positioning

Analyst forecasts suggest moderate upside potential. The monthly forecast stands at $528.12, while yearly projections reach $518.33. Longer-term forecasts indicate $691.38 in three years and $865.00 in five years, suggesting compound annual growth. Technical indicators show RSI of 54.61 indicating neutral momentum, while ADX of 41.55 confirms a strong underlying trend. The stock trades within Bollinger Bands with upper resistance at $684.04 and support at $538.47.

Final Thoughts

Krishana Phoschem Limited delivered solid earnings results with $7.55 billion in revenue and $13.44 EPS, driving a 5.77% stock surge to $634.70. The company demonstrates strong operational fundamentals with 40.65% ROE, 7.45% net margins, and controlled leverage at 1.31x debt-to-equity. Revenue growth of 1.32% and gross profit expansion of 5.25% reflect steady market demand and improving operational efficiency. With a B+ Meyka grade, moderate P/E of 20.96, and solid interest coverage of 9.31x, the company maintains healthy financial positioning. Forward forecasts suggest continued growth trajectory, though investors should monitor agricultura…

FAQs

What were Krishana Phoschem’s actual earnings results on May 4?

Krishana Phoschem reported $7.55 billion revenue and $13.44 EPS. The stock surged 5.77% to $634.70 on strong trading volume of 363,870 shares, significantly above average daily levels.

How does Krishana Phoschem’s valuation compare to peers?

Trading at P/E 20.96 and price-to-sales 1.56 indicates moderate valuation. The PEG ratio of 0.19 suggests attractive pricing relative to growth prospects.

What is Krishana Phoschem’s profitability and financial health?

Strong profitability with 40.65% ROE and 10.98% ROA. Debt-to-equity of 1.31 shows moderate leverage; 9.31x interest coverage and 1.36 current ratio demonstrate solid financial health.

What does Meyka AI’s B+ grade mean for KRISHANA.NS?

B+ grade indicates neutral positioning with strong operational fundamentals. Reflects solid profitability, reasonable valuation, and stable market position, though commodity price volatility warrants monitoring.

What are the growth prospects for Krishana Phoschem?

Recent performance shows 1.32% revenue growth and 5.25% gross profit expansion. Analyst forecasts project $518.33 yearly and $865.00 in five years, supported by 7.45% net margins.

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Earnings estimates are analyst projections and not guarantees of actual results. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.

What brings you to Meyka?

Pick what interests you most and we will get you started.

I'm here to read news

Find more articles like this one

I'm here to research stocks

Ask Meyka Analyst about any stock

I'm here to track my Portfolio

Get daily updates and alerts (coming March 2026)